Enovix (ENVX) Research & Development (2020 - 2026)

Enovix (ENVX) has reported Research & Development for 7 consecutive years, with $24.4 million the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, Research & Development fell 13.16% year-over-year to $24.4 million; the trailing twelve-month figure through Jul 2026 stood at $107.2 million (up 6.45% YoY), and the FY2025 full-year result was $110.3 million, down 11.38% from the prior year.
• Research & Development retreated to $24.4 million in Q3 2026 per ENVX's latest filing, from $26.5 million in the prior quarter.
• Across five years, Research & Development topped out at $48.8 million in Q1 2024 and bottomed at $12.7 million in Q2 2022.
• Historically, Research & Development has averaged $25.0 million across 5 years, with a median of $25.2 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Research & Development surged 127.79% in 2022, then plunged 46.85% in 2025.
• Over 5 years, Research & Development stood at $13.9 million in 2022, then soared by 147.94% to $34.6 million in 2023, then sank by 35.13% to $22.4 million in 2024, then grew by 25.15% to $28.1 million in 2025, then dropped by 12.93% to $24.4 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $24.4 million, $26.5 million, and $28.1 million for Q3 2026, Q2 2026, and Q4 2025 respectively.